Final media advisory for the 4th European Breast Cancer Conference (EBCC-4)

February 19, 2004

Final media alert

Tuesday 16 March - Saturday 20 March 2004
Congress Centrum, Am Dammtor, D-20355, Hamburg, Germany

EBCC-4 is the only forum in Europe that involves all the major players in breast cancer and is expected to attract a record 4,000 delegates from around 80 countries worldwide.

Provisional news briefing programme

Tuesday 16 March 13.00hrs
1. Professor Lars Holmberg: Why breast self-examination can be harmful
2. Dr Alane Koki: Breast cancer chip brings personalised treatment closer
3. Dr Lonneke van de Poll-Franse: Younger breast cancer survivors suffer more, even ten years later

Wednesday 17 March 13.00hrs
1. Dr Youlia Kirova: New findings - BRCA genes and breast conservation - is conservation treatment safe for carriers?
2. Dr Maartje Hooning: New findings from major study of breast cancer treatment and heart disease and intriguing indications that profile for breast cancer risk may protect against heart disease.
3. Dr Robert Paridaens: First results from international study of exemestane versus tamoxifen as first-line treatment in metastatic breast cancer

Thursday 18 March 13.00hrs
1. Dr Eric Winer: Rigorous testing needed for complementary and alternative therapies (CAMs) - which CAMs are safe and which need further investigation?
2. Professor Dennis Holmes: New findings on DCIS and survival - comparing conservation treatment and mastectomy

To find full details of the programme......
Visit the EBCC-4 web site: http://www.fecs.be/conferences/ebcc4

Registration is free to all bona fide media on provision of press credentials

To register now: complete the attached form or register on the web site
http://www.fecs.be/conferences/ebcc4/media.shtml
OR: register on site as from Tuesday 16 March 2004.

If you wish to book accommodation, booking agents details can be found on: http://www.fecs.be/conferences/ebcc4/accommodation.shtml

Further information
FECS' Communication Manager Stuart Bell
Tel: 32-2775-0207
Email: stuart@fecs.be
or
EBCC Media Consultant Margaret Willson
Tel: 44-153-677-2181
Email: m.willson@mwcommunications.org.uk
-end-


ECCO-the European CanCer Organisation

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.